Juan Jaen
Founder bij ARCUS BIOSCIENCES, INC.
Vermogen: 29 M $ op 31-03-2024
Profiel
Juan Carlos Jaen is the founder of Arcus Biosciences, Inc. (founded in 2015), Flexus Biosciences, Inc. (founded in 2013), and PACT Pharma, Inc. (founded in 2016).
He holds the title of President at Arcus Biosciences, Inc. Dr. Jaen's current jobs include being a Director at Hexagon Bio, Inc., R2M Pharma, Inc., Bella Charitable Foundation (since 2015), Breakpoint Therapeutics GmbH, and Shasqi, Inc. Dr. Jaen's former jobs include being a Chemistry Director at Warner-Lambert Co. (1983-1996) and Parke-Davis & Co. Ltd.
(1983-1996), VP-Chemistry & Director-Medicinal Chemistry at Tularik, Inc. (1996-2004), Vice President-Chemistry at Amgen, Inc. (1996-2006), and Chief Scientific Officer & SVP-Drug Discovery at ChemoCentryx, Inc. (2011-2013).
He was also the President and Head of Research & Development at Rapt Therapeutics, Inc. (2013-2015).
Dr. Jaen obtained a doctorate degree from the University of Michigan in 1983 and an undergraduate degree from Universidad Complutense de Madrid in 1983.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARCUS BIOSCIENCES, INC.
1.68% | 27-02-2024 | 1 529 708 ( 1.68% ) | 29 M $ | 31-03-2024 |
Actieve functies van Juan Jaen
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Founder | 01-01-2015 |
R2M Pharma, Inc.
 R2M Pharma, Inc. BiotechnologyHealth Technology R2M Pharma, Inc. develops, discovers, and manufactures pharmaceutical products. The private company is based in San Francisco, CA. | Director/Board Member | - |
Bella Charitable Foundation
 Bella Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Bella Charitable Foundation operates as a grant making charity. The private company is based in Burlingame, CA. | Director/Board Member | 01-06-2015 |
Breakpoint Therapeutics GmbH
 Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany. | Director/Board Member | - |
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Director/Board Member | - |
Shasqi, Inc.
 Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Shasqi, Inc. operates as a biopharmaceutical company. It develops novel chemistry to optimize the healing power of modern medicine. The company was founded by Jose M. Mejia Oneto and is headquartered in San Francisco, CA. | Director/Board Member | - |
Eerdere bekende functies van Juan Jaen
| Bedrijven | Functie | Einde |
|---|---|---|
Flexus Biosciences, Inc.
 Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Founder | 01-04-2015 |
| RAPT THERAPEUTICS, INC. | President | 01-04-2015 |
| CHEMOCENTRYX, INC. | Chief Tech/Sci/R&D Officer | 01-09-2013 |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Juan Jaen
| University of Michigan | Doctorate Degree |
| Universidad Complutense de Madrid | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 11 |
|---|---|
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Health Technology |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Health Technology |
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Health Technology |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
R2M Pharma, Inc.
R2M Pharma, Inc. BiotechnologyHealth Technology R2M Pharma, Inc. develops, discovers, and manufactures pharmaceutical products. The private company is based in San Francisco, CA. | Health Technology |
Bella Charitable Foundation
Bella Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Bella Charitable Foundation operates as a grant making charity. The private company is based in Burlingame, CA. | Miscellaneous |
Breakpoint Therapeutics GmbH
Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany. | Health Technology |
Shasqi, Inc.
Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Shasqi, Inc. operates as a biopharmaceutical company. It develops novel chemistry to optimize the healing power of modern medicine. The company was founded by Jose M. Mejia Oneto and is headquartered in San Francisco, CA. | Health Technology |
